Sopheon plc

Sopheon plc specializes in creating and distributing advanced software solutions, coupled with expert implementation and advisory services, primarily serving clients in North America and Europe. Its key software offerings include Accolade, an enterprise-wide management platform, and ROI Blueprints, designed specifically for project management. These comprehensive tools enable organizations to strategically plan innovation, develop ideas and concepts, define roadmaps, streamline process and project execution, optimize project and portfolio oversight, and efficiently manage resources. They also incorporate features such as advanced analytics, collaborative workflows, product lifecycle management (PLM), portfolio optimization, automated stage-gate processes, capital expenditure management, and strategic initiative planning. Beyond software, Sopheon provides a full suite of professional services, including assessments, consulting, system implementation, user training, and ongoing support, in addition to maintenance, hosting, and Software-as-a-Service (SaaS) options. The company caters to a wide array of industries, including aerospace and defense, automotive, chemicals and coatings, consumer packaged goods, smart product manufacturers, food and beverages, and various industrial and manufacturing sectors. Established in 1993, the company initially operated under the name PolyDoc before being rebranded as Sopheon plc in 1999, and its headquarters are located in West End, United Kingdom.

Sopheon plc trades as SPE.L on LSE. The company is classified in Technology / Software - Application and reports in GBP.

The current profile places the business in Software - Application. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £36.79M of revenue and -£877,000 of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Sopheon plc can be compared against peers such as D4t4 Solutions Plc, Gresham Technologies plc, iEnergizer Limited, i-nexus Global plc, Nexteq plc, Pelatro Plc.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £106.56M, beta of 0.44, and return on equity of -3.0%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

SPE.L currently shows total debt of £464,000 and beta of 0.44. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.sopheon.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.